cells

also known as JROECL19. Human Caucasian oesophageal carcinoma established in 1993 from an adenocarcinoma of gastric cardia/oesophageal gastric junction of a 72 year old male patient.

Cell Type:

GI Tract Epith.

Tissue Origin:

Species:

human

Research Area:

Dermatology/Tissue Engineering

Cell Characteristics:

Suspension

Transfection Information

Lonza Optimized Protocol
Optimization Guideline

Filter:

The table below shows data for the cell type and Nucleofector™ Platform selected. Those data are either based on Lonza Optimized Protocols or on results shared from customers who performed an optimization based on our guidelines. In case no data are shown for the selected Nucleofector™ Platform, please take a look at our optimization strategy to get further guidance on how to easily determine optimal Nucleofection conditions yourself.

Kit	Program	Cells	Efficiency	Viable Cells	Substrate		Format	Platform
V	T-030	1e6	80%	45%	Plasmid (general)	2 µg	100 µl	I/II/2b
V	T-020	1e6	70%	60%	Plasmid (general)	2 µg	100 µl	I/II/2b
V	D-023	1e6	35-40%	80%	Plasmid (general)	2 µg	100 µl	I/II/2b

OE19

Transfection Information